Camilla Bertel Andersen: Protein aggregation in relation to Parkinson’s disease
PhD defence, Monday, 17 December 2018. Camilla Bertel Andersen.
During her PhD studies, Camilla Bertel Andersen researched the protein alpha-synuclein which is involved in Parkinson’s disease. In Parkinson’s disease the alpha-synuclein is found to form toxic aggregates. Camilla Bertel Andersen studied how alpha-synuclein aggregation is inhibited by small molecules and how it self associates into oligomers in the presence of two different products of lipid oxidation. The oligomer was finally studied inside live cells with NMR.
The new research findings contribute to the understanding of how the alpha-synuclein oligomer contributes to neuron death in Parkinson’s disease.
The PhD degree was completed at the Interdisciplinary Nanoscience Center (iNANO), Science and Technology, Aarhus University.
This résumé was prepared by the PhD student.
Time: Monday, 17 December 2018 at 13.15
Place: Building 1593, room 012, the Lecture Theatre, iNANO House, Aarhus University, Gustav Wieds Vej 14, 8000 Aarhus C
Title of PhD thesis: In vitro and in-cell investigations of alpha-synuclein oligomers
Contact information: Camilla Bertel Andersen, e-mail: email@example.com, tel.: +45 6014 9610
Members of the assessment committee:
Senior Researcher Ronald Melki, Paris-Saclay Institute of Neuroscience, Université Paris-Saclay, France
Associate Professor Kaare Teilum, Department of Biology, University of Copenhagen, Denmark
Professor Troels Skrydstrup (chair), iNANO and Department of Chemistry, Aarhus University
Professor Daniel Otzen, iNANO and Department of Molecular Biology and Genetics, Aarhus University
Associate Professor Frans A. A. Mulder, iNANO and Department of Chemistry, Aarhus University
Language: The PhD dissertation will be defended in English
The defence is public.
The PhD thesis is available for reading at the Graduate School of Science and Technology/GSST, Ny Munkegade 120, building 1520 and 1521, 8000 Aarhus C.